Venrock polled 274 executives from health IT startups, insurers, providers and more, to gauge their predictions for future of the healthcare industry.
One survey question asked respondents if the administration will lower drug prices over the next four years.
Here is a breakdown of the responses, as reported by Axios.
1. Drug prices will see meaningful decreases: 5 percent
2. Drug prices will see marginal decreases: 49 percent
3. Drug prices will fall voluntarily in response to public concerns: 19 percent
4. Drug prices will not decrease: 27 percent
To view the full report, click here.
More articles on supply chain:
FedEx launches first customer-facing robot
Harvoni, Sovaldi approved for pediatric patients
Survey: 26% of supply chain leaders considering self-distribution
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
